Run-Long Medtech Secures Nearly RMB 100 Million Series A+ Funding Led by Xingze Capital to Advance Innovation in Sports Medicine Surgical Consumables
Run-Long Medtech
Manufacturer of Sports Medicine Products and Surgical Instruments
Apricot capital
Venture Capital Institution
36Kr has learned that a sports medicine manufacturing enterpriseRun-Long Medtech(Run-Long Medtech) has completed an A+ round of financing amounting to nearly RMB 100 million, with Gelu Capital serving as the exclusive financial advisor for this round.This round of financing occurred less than six months after the previous round., with additional investment from existing shareholder Apricot Capital. This round of financing will be primarily used to advance product innovation and expand market presence.
Run-Long Medtechis an innovative medical device company focused on the field of sports medicine and positioned in the high-end domestic market,36Kr has previously published a detailed report on it.. According to the introduction,Since 2021, Run-Long Medtech has obtained registration certificates for four products, including the “plasma radiofrequency electrode,” and currently holds more than ten NMPA registration certificates.
It is reported that the acquisition of the registration certificate for the plasma radiofrequency ablation probe signifies that Run-Long Medtech has completed its product portfolio in both shaver probes and low-temperature plasma radiofrequency technologies, thereby achieving comprehensive coverage of the consumables sector for arthroscopic debridement procedures in sports medicine.
Run-Long Medtech Product Portfolio
From an industry development perspective, sports medicine is a specialized subfield within orthopedics. However, both globally and in China, the sports medicine sector is currently experiencing rapid growth. According to data from Global Market Insights, the global sports medicine market size is projected to exceed USD 9 billion by 2025, with a compound annual growth rate (CAGR) of nearly 8%. Additionally, according to information from Huajing Intelligence Network, China's sports medicine market size was estimated at nearly RMB 4 billion in 2021, with a CAGR reaching 23.4%.
According to 36Kr, arthroscopic debridement consumables account for 25% of the overall sports medicine consumables market. This segment is the most common and has the highest demand in the field of sports medicine, yet domestically produced products still fail to meet clinical needs in terms of performance and quality. It is reported that Run-Long Medtech has achieved rapid growth in its market share by leveraging the market expansion of these two flagship products.
Further Reading